Drugs / Allogenix Plus
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01006148 | Oct 2009 → Aug 2010 | craniosynostosis | University of Missouri-Columbia | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Allogenix Plus | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01006148 ↗ |
| Modality | Other / unclassified | “Allogenix Plus is a demineralized bone matrix obtained using cortical or cancellous allograft bone” NCT01006148 ↗ |